Episode 367: Abiraterone vs AR inhibitors (Fanta vs Coke) in

Episode 367: Abiraterone vs AR inhibitors (Fanta vs Coke) in Prostate Cancer

Listen now

Description

Chuck Ryan from MSKCC joins to talk about various aspects of AR inhibition in prostate cancer and relative benefits and risks.

More Episodes

Published 11/19/24

Chris Sweeney and Rob Jones join Brian and Tom to discuss the relative merits of different ARPIs in prostate cancer.

Published 11/04/24

Published 11/04/24